Cara Therapeutics (NASDAQ:CARA) Rating Increased to Hold at Zacks Investment Research – Slater Sentinel
Cara Therapeutics (NASDAQ:CARA) Rating Increased to Hold at Zacks Investment Research Slater Sentinel
Source: Investment New Feed
Cara Therapeutics (NASDAQ:CARA) Rating Increased to Hold at Zacks Investment Research Slater Sentinel
Source: Investment New Feed